EUVIMEDEUVIMED entdecken
Crossref

Screening and validation of active components in Rosa roxburghii Tratt for anti-pulmonary fibrosis based on a spectrum-effect relationship

Xiaomeng Wang, Ting Zhou, Shaolin Huang, Heting Zhou, Yihan Ling, Tao Chen, Shuwen Zhang, Wenxi Wang, Chuan Wu, Wenya Yin

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Xiaomeng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Hauptthemen laut MEDLINE: Rosa, Pulmonary Fibrosis, Plant Extracts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rosa roxburghii Tratt (RRT), a fruit with dual medicinal and nutritional applications, exhibits therapeutic potential against pulmonary fibrosis, yet the specific bioactive constituents underlying this effect remain uncharacterized. This study employed an integrated spectrum-effect relationship to systematically identify RRT's principal anti-pulmonary fibrosis components. Our findings demonstrate that five different polar extracts of RRT (RRTEs) differentially attenuated bleomycin-induced pulmonary fibrosis in murine models, with the ethyl acetate fraction (EAE) showing superior therapeutic efficacy. HPLC-Q-Exactive Orbitrap MS identified 56 compounds, and screened out four active ingredients related to anti-pulmonary fibrosis by spectrum-effect relationship. In vitro experiments revealed that ellagic acid, gallic acid and syringic acid inhibited fibroblast migration, attenuated intracellular ROS overproduction, and downregulated the expression levels of α-SMA and collagen I. In summary, we established for the first time a spectrum-effect relationship between RRT and pulmonary fibrosis, elucidated the key components, and provided a foundation for future clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaPulmonary FibrosisPlant ExtractsAnimalsBleomycinMiceFibroblastsMaleGallic AcidHumansDisease Models, AnimalEllagic AcidReactive Oxygen SpeciesCell MovementMice, Inbred C57BLLungFruitCollagen Type IActins

Stichwörter der Autor:innen

Multivariate statistical analysisPulmonary fibrosisRosa roxburghii TrattSpectrum-effect relationship

Substanzen

BleomycinPlant ExtractsGallic Acidsyringic acidEllagic AcidReactive Oxygen SpeciesCollagen Type IActins

Autor:innen und Institutionen

  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
  • Chengdu Institute of Product Quality Inspection Co., Ltd, Chengdu 610015, China.
  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Electronic address: yinwenya@scu.edu.cn.

Förderung

  • Science and Technology Department of Sichuan Province

Zitieren

APA

Wang, X., Zhou, T., Huang, S., Zhou, H., Ling, Y., Chen, T., Zhang, S., Wang, W., Wu, C., & Yin, W. (2025). Screening and validation of active components in Rosa roxburghii Tratt for anti-pulmonary fibrosis based on a spectrum-effect relationship. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114536

Vancouver

Wang X, Zhou T, Huang S, Zhou H, Ling Y, Chen T, et al. Screening and validation of active components in Rosa roxburghii Tratt for anti-pulmonary fibrosis based on a spectrum-effect relationship. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114536

BibTeX
@article{Wang2025,
  author = {Wang, Xiaomeng and Zhou, Ting and Huang, Shaolin and Zhou, Heting and Ling, Yihan and Chen, Tao and Zhang, Shuwen and Wang, Wenxi and Wu, Chuan and Yin, Wenya},
  title = {Screening and validation of active components in Rosa roxburghii Tratt for anti-pulmonary fibrosis based on a spectrum-effect relationship},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114536}
}
Kostenlos starten →